Add Yahoo as a preferred source to see more of our stories on Google. Speaker of the House Mike Johnson speaks to reporters at the U.S. Capitol on Feb. 3, 2026. In the final two years of Joe Biden's ...

Most Windows 11 users rely on the Windows Security graphical interface to run antivirus scans, but the command line offers a faster and more flexible alternative — especially when the GUI is ...

SNC’s site for E-4C work in Dayton, Ohio, has rapidly grown since the company won the competition in 2024. Credit: SNC The future backbone of U.S. nuclear command and control is taking shape in a set ...

The Army will kick off its new retention bonus system next month, using physical fitness scores, technical expertise and commander evaluations to determine a soldier’s payout to reenlist. “We were ...

The Seattle Times’ Education Lab examines the educational system from early childhood through post-secondary. Education Lab is supported by Gates Foundation, Ballmer Group and The Norcliffe Foundation ...

AI expert Allie K. Miller demonstrates Anthropic's Claude Cowork, an AI agent tool that automates extensive business tasks. It analyzes documents, conducts research, builds interactive dashboards, and ...

I can't stand opening the Microsoft Store. It's slow to load, confusing to browse, and full of ads for things I don't care about. Luckily, thanks to a new feature, I don't have to open the Microsoft ...

Federal Communications Commission Chair Brendan Carr is urging broadcast media companies to air “patriotic, pro-America content” in a new campaign aligned with President Donald Trump’s Freedom 250 ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

In case you've faced some hurdles solving the clue, Software program run through a browser, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.